Pneumonic plague epidemic in Northeast China in 1910–1911: Dr. Wu Lien-Teh’s epidemic preventive system for plague control

doi:10.1007/s11684-018-0613-4

Front. Med.

2018, Vol. 12

Issue (1) : 113-115 https://doi.org/10.1007/s11684-018-0613-4

COMMENTARY

Pneumonic plague epidemic in Northeast China in 1910–1911: Dr. Wu Lien-Teh’s epidemic preventive system for plague control

Qingmeng Zhang, Fengmin Zhang(

), Baofeng Yang(

)

Wu Lien-Teh Institute, Harbin Medical University, Harbin 150081, China

Download: PDF(140 KB) HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract

Pneumonic plague that originated in Russian Siberia broke out in Northeast China in October 1910–March 1911. On the basis of field visits, autopsy, bacteriological identification, and close collaboration with local authorities and international colleagues, Dr. Wu Lien-Teh implemented a series of efficient antiplague measures, which successfully controlled the development of an extraordinary epidemic plague. In his subsequent work, Dr. Wu demonstrated the respiratory transmission of pneumonic plague and tarbagans’ role in this spread. Dr. Wu’s academic and cultural contributions are valuable in the medical progress in China.

Keywords pneumonic plague prevention epidemic control Wu Lien-Teh

Corresponding Author(s): Fengmin Zhang,Baofeng Yang

Just Accepted Date: 25 December 2017 Online First Date: 25 January 2018 Issue Date: 06 February 2018

Cite this article:

Qingmeng Zhang,Fengmin Zhang,Baofeng Yang. Pneumonic plague epidemic in Northeast China in 1910–1911: Dr. Wu Lien-Teh’s epidemic preventive system for plague control[J]. Front. Med., 2018, 12(1): 113-115.

URL:

https://academic.hep.com.cn/fmd/EN/10.1007/s11684-018-0613-4
https://academic.hep.com.cn/fmd/EN/Y2018/V12/I1/113

Fig.1 Academic and cultural contributions of Dr. Wu Lien-Teh in Harbin. (A) Harbin Medical University as a new campus in 1954. (B) Wu Lien-Teh Memorial in the original location and buildings of North Manchurian Plague Prevention Service and its affiliated Pingchiang Hospital in Harbin.

1	[No authors listed.] Report of the International Plague Conference. Manila Bureau of Publishing, 1912
2	LT Wu . Plague fighter: the authobiography of a modern Chinese physician. Cambridge: W. Heffer & Sons Ltd., 1959
3	LT Wu , WH Chun, R Pollitzer. Plague in Manchuria: I. Observations made during and after the Second Manchurian Plague Epidemic of 1920–21. II. The Role of the tarabagan in the epidemiology of plague. J Hyg (Lond) 1923; 21(3): 307–358 pmid: 20474782
4	LT Wu. North Manchurian Plague Prevention Service Report (1911–1913). Cambridge: Cambridge University Press, 1914
5	LT Wu, GS Woodhead. Note on the histology of some of the lesions found in pneumonic plague. J Pathol Bacteriol 1915; 19(1): 1–32 https://doi.org/10.1002/path.1700190101
6	Chinese Plague Commission. Views of Harbin Fuchiatien taken during the plague epidemic, December 1910–March 1911. Shanghai: Commercial Press, Ltd., 1911
7	LT Wu , GL Tuck. Investigations into the relationship of the tarabagan (Mongolian marmot) to plague. Lancet 1913; 182(4695): 529–535 https://doi.org/10.1016/S0140-6736(01)76466-5
8	LT Wu, F Eberson. Transmission of pulmonary and septicaemic plague among marmots. National Med J China 1916; 2(3): 6–13
9	LT Wu. A treatise of pneumonic plague. League of Nations, Health Organization. 1926
10	LT Wu , JWH Chun, R Pollitzer, CY Wu. A Manual for Medical and Public Health Workers. National Quarantine Service, China. 1936
11	MLA style: “Nomination Database.” Nobelprize.org. Nobel Media AB 2014. Web. 23 Nov 2017.

[1]	Yi Zhang, Haocheng Zhang, Wenhong Zhang. SARS-CoV-2 variants, immune escape, and countermeasures[J]. Front. Med., 2022, 16(2): 196-207.
[2]	Solmaz Ohadian Moghadam, Seyed Ali Momeni. Human microbiome and prostate cancer development: current insights into the prevention and treatment[J]. Front. Med., 2021, 15(1): 11-32.
[3]	Zhihang Peng, Wenyu Song, Zhongxing Ding, Quanquan Guan, Xu Yang, Qiaoqiao Xu, Xu Wang, Yankai Xia. Linking key intervention timings to rapid declining effective reproduction number to quantify lessons against COVID-19[J]. Front. Med., 2020, 14(5): 623-629.
[4]	Cenyi Shao, Shijian Li, Feng Zhu, Dahai Zhao, Hui Shao, Haixiao Chen, Zhiruo Zhang. Taizhou’s COVID-19 prevention and control experience with telemedicine features[J]. Front. Med., 2020, 14(4): 506-510.
[5]	Eun Young Lee, Kun-Ho Yoon. Epidemic obesity in children and adolescents: risk factors and prevention[J]. Front. Med., 2018, 12(6): 658-666.
[6]	Yang Sun,Chenze Li,Lina Zhang,Dong Hu,Xudong Zhang,Ting Yu,Min Tao,Dao Wen Wang,Xiaoqing Shen. Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients[J]. Front. Med., 2017, 11(1): 53-61.
[7]	Chunsong Hu,Qinghua Wu. Health: a dream from reality to the future[J]. Front. Med., 2016, 10(2): 233-235.
[8]	Yi Cao. Environmental pollution and DNA methylation: carcinogenesis, clinical significance, and practical applications[J]. Front. Med., 2015, 9(3): 261-274.
[9]	James S. Park, Calvin Pan. Current recommendations of managing HBV infection in preconception or pregnancy[J]. Front. Med., 2014, 8(2): 158-165.
[10]	Rui Yu, Rong Fan, Jinlin Hou. Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China[J]. Front. Med., 2014, 8(2): 135-144.
[11]	Yiling Wu. Construction of the vessel-collateral theory and its guidance for prevention and treatment of vasculopathy[J]. Front Med, 2011, 5(2): 118-122.
[12]	Shi-Ming CHENG MD, Yu-Ji LAI MS, Er-Yong LIU MS, Lin ZHOU MD, Xue-Jing WANG MS, Qiu-Lan CHEN MS, Dong-Ming LI MS, Ning WANG MD, . Study on factors affecting TB/HIV co-infection in four counties of China[J]. Front. Med., 2010, 4(2): 185-191.
[13]	Jun-Jie XIAO MD, Yi-Han CHEN MD, PhD, . Prevalence of cardiovascular diseases in China[J]. Front. Med., 2010, 4(1): 16-20.
[14]	Qi MEI MM, Zhe CAO MM, Hua XIONG MD, Yuan CHEN MD, . Preliminary results of gentamycin combined with sodium bicarbonate for prevention of irinotecan-induced diarrhea[J]. Front. Med., 2009, 3(4): 470-474.

Viewed

Full text

Abstract

Cited

Shared

Discussed